Low-density lipoprotein cholesterol reduction and prevention of cardiovascular disease.
作者信息
Stein Evan A
出版信息
Mayo Clin Proc. 2009 Apr;84(4):307-9. doi: 10.1016/S0025-6196(11)60537-5.
Abstract
摘要
相似文献
1
Low-density lipoprotein cholesterol reduction and prevention of cardiovascular disease.低密度脂蛋白胆固醇降低与心血管疾病的预防
Mayo Clin Proc. 2009 Apr;84(4):307-9. doi: 10.1016/S0025-6196(11)60537-5.
2
Role of ezetimibe in the prevention of cardiovascular disease: absence of evidence.依泽替米贝在心血管疾病预防中的作用：缺乏证据。
Arch Med Res. 2010 Nov;41(8):649-50. doi: 10.1016/j.arcmed.2010.10.008.
3
Lipid-lowering study raises issues of therapy's value.降脂研究引发了关于该疗法价值的问题。
Am J Health Syst Pharm. 2008 Apr 1;65(7):594-5. doi: 10.2146/news080027.
4
[Clinical efficacy of ezetimibe and combined use with statins].依折麦布及与他汀类药物联合使用的临床疗效
Rev Clin Esp. 2005 Oct;205(10):496-8. doi: 10.1157/13079765.
5
Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.降低低密度脂蛋白胆固醇：他汀类药物、依泽替米贝、胆汁酸螯合剂及联合用药：疗效与安全性比较
Endocrinol Metab Clin North Am. 2009 Mar;38(1):79-97. doi: 10.1016/j.ecl.2008.11.007.
6
Effects of ezetimibe add-on to statin therapy on adipokine production in patients with metabolic syndrome and stable vascular disease.依折麦布添加治疗对代谢综合征和稳定血管疾病患者脂联素产生的影响。
J Cardiovasc Pharmacol. 2010 Sep;56(3):241-5. doi: 10.1097/FJC.0b013e3181e7fd74.
7
[New indications and therapeutic objectives for dyslipidemia].[血脂异常的新适应症和治疗目标]
Aten Primaria. 2006 Nov 30;38(9):473-5. doi: 10.1157/13095046.
8
Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.依折麦布在无法耐受他汀类药物或尽管服用他汀类药物仍无法达到低密度脂蛋白胆固醇目标的患者中的作用。
Curr Med Res Opin. 2007 Sep;23(9):2183-92. doi: 10.1185/030079907X226267.
9
[Ezetimibe in clinical practice: from laboratory investigations to the IMPROVE-IT trial results].[依折麦布在临床实践中的应用：从实验室研究到IMPROVE-IT试验结果]
G Ital Cardiol (Rome). 2015 Jul-Aug;16(7-8 Suppl 1):3S-14S. doi: 10.1714/1972.21370.
10
[Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].[胆固醇目标现在更容易实现。每天只需一片药就能降低一半的低密度脂蛋白胆固醇]
MMW Fortschr Med. 2005 Nov 10;147(45):55.
引用本文的文献
1
Risk Factors Associated with Failure to Achieve the Low Density Lipoprotein Cholesterol Therapeutic Target in Patients with Acute Coronary Syndrome: A Longitudinal, Single Centre Investigation.急性冠状动脉综合征患者低密度脂蛋白胆固醇治疗目标未达标的相关危险因素：一项纵向单中心研究
High Blood Press Cardiovasc Prev. 2019 Feb;26(1):37-43. doi: 10.1007/s40292-019-00298-5. Epub 2019 Jan 25.
2
Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.与行业相关的科学出版物中的利益冲突、作者身份及信息披露：侵权律师与医学期刊的编辑监督
Mayo Clin Proc. 2009 Sep;84(9):811-21. doi: 10.4065/84.9.811.
本文引用的文献
1
Impact of ezetimibe on atherosclerosis: is the jury still out?依折麦布对动脉粥样硬化的影响：尚无定论？
Mayo Clin Proc. 2009 Apr;84(4):353-61. doi: 10.1016/S0025-6196(11)60545-4.
2
Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery disease.强化降低低密度脂蛋白胆固醇水平以预防冠状动脉疾病的一级预防。
Mayo Clin Proc. 2009 Apr;84(4):345-52. doi: 10.1016/S0025-6196(11)60544-2.
3
Additional lipid lowering trials using surrogate measurements of atherosclerosis by carotid intima-media thickness: more clarity or confusion?利用颈动脉内膜中层厚度对动脉粥样硬化进行替代测量的额外降脂试验：会带来更多清晰认识还是造成更多困惑？
J Am Coll Cardiol. 2008 Dec 16;52(25):2206-9. doi: 10.1016/j.jacc.2008.11.002.
4
Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.他汀类药物单药治疗与他汀类药物联合依折麦布治疗对2型糖尿病患者颈动脉粥样硬化的影响：SANDS（本土糖尿病患者动脉粥样硬化阻断研究）试验
J Am Coll Cardiol. 2008 Dec 16;52(25):2198-205. doi: 10.1016/j.jacc.2008.10.031.
5
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.瑞舒伐他汀预防C反应蛋白升高的男性和女性发生血管事件。
N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.
6
The statins in preventive cardiology.预防心脏病学中的他汀类药物。
N Engl J Med. 2008 Oct 2;359(14):1426-7. doi: 10.1056/NEJMp0806479.
7
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.阿托伐他汀强化降脂治疗冠心病合并慢性肾脏病患者：TNT（治疗达新目标）研究
J Am Coll Cardiol. 2008 Apr 15;51(15):1448-54. doi: 10.1016/j.jacc.2007.11.072.
8
Simvastatin with or without ezetimibe in familial hypercholesterolemia.辛伐他汀联合或不联合依折麦布治疗家族性高胆固醇血症
N Engl J Med. 2008 Apr 3;358(14):1431-43. doi: 10.1056/NEJMoa0800742. Epub 2008 Mar 30.
9
Illuminating HDL--is it still a viable therapeutic target?解读高密度脂蛋白——它仍是一个可行的治疗靶点吗？
N Engl J Med. 2007 Nov 22;357(21):2180-3. doi: 10.1056/NEJMe0707210. Epub 2007 Nov 5.
10
European guidelines on cardiovascular disease prevention in clinical practice: executive summary.欧洲临床实践中心血管疾病预防指南：执行摘要
Atherosclerosis. 2007 Sep;194(1):1-45. doi: 10.1016/j.atherosclerosis.2007.08.024. Epub 2007 Sep 18.
Zotero 插件